GRPR and cancer: Liu et al. conducted a pioneering comparative evaluation of RGD-BBN BRL radiolabeled with 18F, 64Cu, and 68Ga for dual-targeted PET imaging of breast cancer, with the aim of exploiting the overexpression of αvβ3 integrins and GRPR in tumor neovasculature and cancer cells, respectively.